Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEDEVCO CORP Director's Dealing 2013

Sep 9, 2013

34546_dirs_2013-09-09_25fc2c3a-f29f-46aa-99c0-2d259ba26765.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PEDEVCO CORP (PEDO)
CIK: 0001141197
Period of Report: 2013-09-05

Reporting Person: PETERSON MICHAEL L (Director, Exec VP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-05 Common Stock S 2100 $4.50 Disposed 697016 Direct
2013-09-06 Common Stock S 3000 $4.50 Disposed 694016 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12806 Indirect
Common Stock 26668 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Incentive Stock Option (Right to Buy) $.51 2022-06-18 Common Stock (63800) 63800 Direct
Non-Qualified Stock Option (Right to Buy) $.24 2021-10-07 Common Stock (100000) 100000 Direct
Non-Qualified Stock Option (Right to Buy) $.51 2022-06-18 Common Stock (269534) 269534 Direct
Non-Qualified Stock Option (Right to Buy) $67.20 2018-05-28 Common Stock (447) 447 Direct
Non-Qualified Stock Option (Right to Buy) $30.24 2021-02-02 Common Stock (2977) 2977 Direct

Footnotes

F1: 2,100 shares were sold at $4.50 per share pursuant to Reporting Person's Rule 10b5-1 Sales Plan established December 17, 2012 and administered by Oppenheimer and Co. Inc.

F2: Includes 250,000 shares and 325,000 shares issued pursuant to restricted stock agreements, 111,567 balance of vested stock initially issued pursuant to a restricted stock agreement and 7449 shares issued pursuant to a debt conversion.

F3: Represents 13,334 shares of the Issuer's common stock owned by each of the Reporting Person's two minor children.

F4: 3,000 shares were sold at $4.50 per share pursuant to Reporting Person's Rule 10b5-1 Sales Plan established December 17, 2012 and administered by Oppenheimer and Co. Inc.